Type 2 diabetes is a long-term condition that affects how the body uses sugar, also called glucose. In people with this condition, the body either does not produce enough insulin or cannot use insulin properly.
This leads to high blood sugar levels, which over time can damage the heart, blood vessels, eyes, kidneys, and nerves. Because of these risks, keeping blood sugar under control is very important.
One of the most common treatments for type 2 diabetes is a medicine called metformin. It is usually the first drug doctors prescribe because it is effective, safe, and affordable. However, for many people, metformin alone is not enough to keep blood sugar levels within a healthy range. In these cases, doctors often add a second medication.
A large and important study has now looked at which additional medicines work best when combined with metformin. The research was led by Dr. Henry Burch and The GRADE Study Research Group. It was published in the well-known medical journal The New England Journal of Medicine.
The study included 5,047 people with type 2 diabetes. All of them were already taking metformin, but their blood sugar was not fully controlled. The participants came from different backgrounds, including a wide range of ages, sexes, races, and ethnic groups. This diversity makes the results more useful for real-world patients.
The researchers divided the participants into four groups. Each group received one extra diabetes medicine in addition to metformin. The four medicines tested were sitagliptin, liraglutide, glimepiride, and insulin glargine.
These drugs work in different ways. Some help the body release more insulin, while others improve how the body uses insulin or slow down how quickly sugar enters the blood.
The study followed the participants for about four years. During this time, the researchers checked how well each drug combination kept blood sugar levels within the target range.
The results showed that not all combinations worked equally well. People who took liraglutide or insulin glargine along with metformin were able to keep their blood sugar under control for the longest time. On average, these two treatments worked about six months longer than sitagliptin, which was the least effective of the four.
This difference may seem small, but in long-term conditions like diabetes, even a few extra months of good control can make a meaningful difference in reducing complications.
Another important finding was that the results were similar across different groups of people. The effectiveness of the drugs did not change much based on age, sex, or ethnic background. This means the findings are likely helpful for many patients, not just a specific group.
However, the study also revealed a major challenge. Even with these treatments, nearly 75 percent of participants could not keep their blood sugar within the target range over the full four years.
This shows how difficult it is to manage type 2 diabetes over time. It also suggests that current treatments may not be enough for many people, and better options are still needed.
The researchers also looked at heart health, which is very important for people with diabetes. High blood sugar can increase the risk of heart attacks and strokes.
The study found that people taking liraglutide had the lowest risk of heart problems among the four groups. This suggests that liraglutide may offer extra protection for the heart, in addition to lowering blood sugar.
These findings give doctors useful guidance when choosing medications. While several options are available, some may provide longer-lasting control or added benefits. At the same time, the study shows that treatment needs to be flexible. Doctors may need to adjust medications over time to keep blood sugar under control.
For people living with type 2 diabetes, this research highlights the importance of working closely with healthcare providers. Regular check-ups and blood sugar monitoring can help ensure that treatment is working as expected. If not, changes can be made early.
It is also important to remember that medication is only one part of diabetes care. Healthy eating, regular physical activity, and maintaining a healthy weight all play key roles in managing the condition.
In simple terms, this study shows that combining metformin with liraglutide or insulin glargine may be the most effective way to control blood sugar over the long term. It also shows that managing diabetes is not easy and often requires ongoing effort and adjustment.
The study was published in The New England Journal of Medicine and provides strong evidence to help improve treatment decisions. It is an important step toward better care for people with type 2 diabetes.
If you care about diabetes, please read studies about diabetes and vitamin B12, and the right diet for people with type 2 diabetes.
For more health information, please see recent studies about how to eat smart with diabetes, and turmeric and vitamin D: a duo for blood pressure control in diabetic patients.
Copyright © 2026 Knowridge Science Report. All rights reserved.
